A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Clinical trial NCT04309578 · COMPLETED
Trial details
- NCT number
- NCT04309578
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-12
- Primary completion
- 2024-07-09
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.